Rare lephants
Screener

SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Nov 6, 2013 8-K
4 Oct 15, 2013 PRIMARY DOCUMENT
4 Oct 15, 2013 PRIMARY DOCUMENT
8-K Sep 18, 2013 8-K
424B5 Sep 13, 2013 424B5
8-K Sep 13, 2013 8-K
424B5 Sep 12, 2013 424B5
424B3 Aug 16, 2013 424B3
EFFECT Aug 15, 2013
CORRESP Aug 13, 2013
S-3/A Aug 9, 2013 AMENDMENT NO. 1 TO FORM S-3
S-8 Aug 9, 2013 S-8
10-Q Aug 9, 2013 10-Q
8-K Aug 8, 2013 8-K
8-K Jul 3, 2013 8-K
4 Jul 3, 2013 PRIMARY DOCUMENT
4 Jul 3, 2013 PRIMARY DOCUMENT
4 Jul 3, 2013 PRIMARY DOCUMENT
4/A Jun 17, 2013 PRIMARY DOCUMENT
4 Jun 17, 2013 PRIMARY DOCUMENT
4 Jun 13, 2013 PRIMARY DOCUMENT
EFFECT Jun 12, 2013
CORRESP Jun 10, 2013
CT ORDER Jun 6, 2013
CT ORDER Jun 6, 2013
← Newer Page 34 of 51 · 1272 filings Older →